European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. SPCX
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
(NYSE: OGN) Delayed: 13.44 +0.04 (0.30%)
Previous Close $13.40    52 Week High $8.00 
Open $13.40    52 Week Low $8.00 
Day High $13.44    P/E N/A 
Day Low $13.39    EPS $0.00 
Volume 269,547